Showing results (821-830 of 2,774) with videos related to

Sort By:
Pageof 278
Bioanalysis|December 15, 2017
Laser desorption/ionization MS imaging of cancer kidney tissue on silver nanoparticle-enhanced targetAdrian Arendowski, Joanna Nizioł, Krzysztof Ossoliński, et al.
Bioanalysis|January 24, 2019
Evaluation of polysaccharide-based chiral stationary phases in modern SFC-MS/MS for enantioselective bioanalysisLiuxi Chen, Brian Dean, Xiaorong Liang
Bioanalysis|January 22, 2019
HPLC-MS/MS-based analysis of everolimus in rabbit aqueous humor: pharmacokinetics of in situ gel eye drops of suspensionZhan Tang, Ling Wang, Zhifang Xia, et al.
Bioanalysis|December 19, 2019
Simultaneous determination of Rivaroxaban and TAK-438 in rat plasma by LC-MS/MS: application to pharmacokinetic interaction studyLibin Wang, Shouchang Gai, Xiaorui Zhang, et al.
Bioanalysis|December 19, 2019
Welcome to volume 12 of BioanalysisSankeetha Nadarajah
Bioanalysis|December 20, 2019
Effect of blood volume on analytical bias in dried blood spots prepared for newborn screening external quality assuranceStuart J Moat, Catherine Dibden, Lesley Tetlow, et al.
Bioanalysis|December 13, 2019
Approaches to improve drug tolerance and target tolerance in the assessment of neutralizing anti-drug antibodiesBonnie Wu, Megan Schnarr, James L Devlin, et al.
Bioanalysis|December 13, 2019
Determination of apatinib and its three active metabolites by UPLC-MS/MS in a Phase IV clinical trial in NSCLC patientsShaoxing Guan, Wei Shi, Zerui Zhao, et al.
Bioanalysis|December 11, 2019
2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 - Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62)Steven Piccoli, Devangi Mehta, Alessandra Vitaliti, et al.
Bioanalysis|February 17, 2018
Incorporating dried blood spot LC-MS/MS analysis for clinical development of a novel oncolytic agentEnaksha R Wickremsinhe, Sophie Callies, Chris A Schmalz, et al.
Pageof 278